In summary, our study provides evidence supporting a model in which CLGN, upregulated by endoplasmic reticulum stress (ERS), contributes to hepatocellular carcinoma (HCC) progression and drug resistance, potentially via the NF-κB pathway. The gene discussed is CLGN; the disease is hepatocellular carcinoma.